Neuron23
Phase 2Neuron23 is developing a precision medicine approach designed to improve the lives of people with Parkinson’s disease.
Founded
2018
Focus
AI / Machine Learning
About
Neuron23 is developing a precision medicine approach designed to improve the lives of people with Parkinson’s disease.
Funding History
3Total raised: $313.5M
Series C$100MSoftBank Vision Fund 2Dec 15, 2022
Series B$113.5MCowen Healthcare InvestmentsJun 15, 2021
Series A$100MWestlake Village BioPartnersOct 15, 2020
Company Info
TypePrivate
Founded2018
LocationSouth San Francisco, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile